Skip to main content

Find Clinical Trials

Home
Conditions
Lymphangioleiomyomatosis

Clinical trial condition

Lymphangioleiomyomatosis

Explore clinical trials studying Lymphangioleiomyomatosis. Study availability and eligibility vary by location and protocol.

41 public trials 10 recruiting studies

Refine in advanced search Browse all conditions

Lymphangioleiomyomatosis trial results

Completed

The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1)

NCT02116712

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: University of Cincinnati Cincinnati, Ohio, United States

Baylor College of Medicine Houston, Texas, United States

University of Texas Health Science Center-Houston Houston, Texas, United States

View Trial Details

Completed

Lymphangioleiomyomatosis (LAM) Registry

NCT00005486

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
Locations: Not specified

View Trial Details

Completed

Pulmonary Rehabilitation in Lymphangioleiomyomatosis

NCT02009241

Conditions: Behavior, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Pulmonary Division, Heart Institute (InCor), University of Sao Paulo Medical School São Paulo, Brazil

View Trial Details

Completed

Doxycycline In Lymphangioleiomyomatosis (LAM)

NCT00989742

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +23 more
Locations: Nottingham University Hospitals Nottingham, United Kingdom

View Trial Details

Completed

RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM

NCT00457964

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +27 more
Locations: Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

View Trial Details

Completed

Pulmonary Hypertension in Lymphangioleiomyomatosis

NCT00960895

Conditions: Cardiovascular Diseases, Hemic and Lymphatic Diseases, Hypertension, +16 more
Locations: Louis Pradel Hospital Lyon, University of Lyon, France

View Trial Details

Completed

Treatment With Octreotide in Patients With Lymphangioleiomyomatosis

NCT00005906

Conditions: Ascites, Chylothorax, Chylous Ascites, +21 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Official Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM)

NCT00001869

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +29 more
Locations: National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States

View Trial Details

Completed

Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM

NCT00457808

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +23 more
Locations: Cincinnati Childrens Hospital Medical Center Cincinnati, Ohio, United States

View Trial Details

Active, Not Recruiting

Feasibility of [11C]Acetate-PET in LAM and TSC

NCT05467397

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +24 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

View Trial Details